What is Nexalin Technology, Inc.'s market cap?

Nexalin Technology, Inc. (NXL) has a market capitalization of $9.7M and trades on NASDAQ.

Who are Nexalin Technology, Inc.'s competitors?

Nexalin Technology, Inc.'s key competitors include Neuronetics, Inc., Neuropace, Inc. Common Stock, ClearPoint Neuro, Inc. Common Stock, and others. These companies compete in similar markets and product categories.

Who does Nexalin Technology, Inc. partner with?

Nexalin Technology, Inc.'s notable partners include Lindus Health Limited, GreenLight Venture LLC, University of California, San Diego, and others.

What subsidiaries does Nexalin Technology, Inc. have?

Nexalin Technology, Inc.'s subsidiaries include Nexalin Technology, Inc. (China) WOFE.

Where is Nexalin Technology, Inc. headquartered?

Nexalin Technology, Inc. is headquartered in United States of America and employs approximately 6 people. It has been publicly traded since 2022.

Nexalin Technology, Inc.

NXL

Nexalin Technology, Inc. is a medical device company that designs and develops non-invasive neurostimulation products to treat mental health conditions such as anxiety, insomnia, and depression.

Market cap

$9.73M-45.0%

Table of contents

Earnings

Q1 2026 report

May 8, 2026

Revenue$15.0KMiss by $50.0 EPS-$0.11Miss by $0.01

Read the full report

Next report

Sep 2, 2026 (in a month)

Revenue estimate$90.0K

EPS estimate-$0.10

Competitors

By market cap

LivaNova$4.4B+86.8%

Inspire Medical Systems$1.5B-61.9%

Neuropace, Inc.$521.6M+82.0%

Orthofix Medical Inc.$481.0M+7.7%

ClearPoint Neuro$437.8M+41.2%

Neuronetics$126.0M-57.9%

Neuraxis$83.5M+223%

Nexalin Technology, Inc.$9.7M-49.9%

By revenue growth

Neuronetics+69.5%

ClearPoint Neuro+26.0%

Neuropace, Inc.+18.1%

LivaNova+12.4%

Inspire Medical Systems+8.9%

Orthofix Medical Inc.+2.6%

By net margin

Inspire Medical Systems14.33%+6.4pp

Orthofix Medical Inc.-7.27%+10.5pp

LivaNova-16.12%-22.5pp

Neuropace, Inc.-21.67%+7.8pp

Neuronetics-24.48%+29.8pp

ClearPoint Neuro-71.57%-7.1pp

Profile

Nexalin Technology, Inc. is a medical device company that designs and develops non-invasive neurostimulation products to treat mental health conditions such as anxiety, insomnia, and depression. The company utilizes a proprietary bioelectronic waveform technology intended to stimulate deep brain structures without the side effects associated with pharmaceuticals or psychotherapy. Its core value proposition lies in providing a drug-free, undetectable treatment modality that can be administered in both clinical and home-based virtual settings.

Competitive position

Nexalin is an emerging player in the neurostimulation market, differentiating itself through a high-milliamp proprietary waveform and a virtual clinic model designed to reduce the stigma of mental health treatment.

GeographiesUnited States, China, Brazil, Oman

Customer segmentsHealthcare providers, Government and military, Direct-to-consumer (via prescription)

Business modelHardware-as-a-Service, Razor-and-blade, Direct-to-provider, Telehealth integration

SuppliersThird-party electronics manufacturers, Software developers, Regulatory consultants, Clinical research organizations

CustomersPsychiatrists, Veterans Affairs hospitals, Department of Defense, Individual patients

CountryUnited States of America

Listed2022

Employees6.0

CEOMark White

SectorHealthcare

IndustryMedical - Devices

Websitenexalin.com

FilingsSEC EDGAR

Questions, answered.

What is Nexalin Technology, Inc.'s market cap?: Nexalin Technology, Inc. (NXL) has a market capitalization of $9.7M and trades on NASDAQ.
Who are Nexalin Technology, Inc.'s competitors?: Nexalin Technology, Inc.'s key competitors include Neuronetics, Inc., Neuropace, Inc. Common Stock, ClearPoint Neuro, Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does Nexalin Technology, Inc. partner with?: Nexalin Technology, Inc.'s notable partners include Lindus Health Limited, GreenLight Venture LLC, University of California, San Diego, and others.
What subsidiaries does Nexalin Technology, Inc. have?: Nexalin Technology, Inc.'s subsidiaries include Nexalin Technology, Inc. (China) WOFE.
Where is Nexalin Technology, Inc. headquartered?: Nexalin Technology, Inc. is headquartered in United States of America and employs approximately 6 people. It has been publicly traded since 2022.